4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000238
EVP, Finance & CFO sold 49,800 shares at $65.26 ($3,249,734)
- EVP, Finance & CFO acquired 49,800 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
HOUGEN ELIZABETH L · EVP, Finance & CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-30 | Exercise or conversion : show line 1 in the form 10b5-1 | +49,800 | $53.77 | $2,677,746 | 160,300 | D |
| 2025-09-30 | Sale : show line 2 in the form 10b5-1 | −49,800 | $65.26 | $3,249,734 | 110,500 | D |
| Open-market sales · 49,800 sh · avg $65.26 · $3,249,734 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-30 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −49,800 | 0 | D |
Loading xslF345X05/edgardoc.xml…